These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2419952

  • 1. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
    Fuller RW, Mason NR, Snoddy HD, Perry KW.
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
    [Abstract] [Full Text] [Related]

  • 2. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
    Fuller RW, Snoddy HD, Molloy BB.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):454-9. PubMed ID: 2430093
    [Abstract] [Full Text] [Related]

  • 3. Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo.
    Fuller RW, Snoddy HD, Mason NR, Molloy BR.
    Eur J Pharmacol; 1978 Nov 01; 52(1):11-6. PubMed ID: 720384
    [Abstract] [Full Text] [Related]

  • 4. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
    Fuller RW, Perry KW.
    J Pharmacol Exp Ther; 1989 Jan 01; 248(1):50-6. PubMed ID: 2521515
    [Abstract] [Full Text] [Related]

  • 5. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat.
    Fone KC, Austin RH, Topham IA, Kennett GA, Punhani T.
    Br J Pharmacol; 1998 Apr 01; 123(8):1707-15. PubMed ID: 9605579
    [Abstract] [Full Text] [Related]

  • 6. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB, Battaglia G, Creese I.
    Mol Pharmacol; 1985 Dec 01; 28(6):487-94. PubMed ID: 2867462
    [Abstract] [Full Text] [Related]

  • 7. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA, Kellar KJ.
    Mol Pharmacol; 1989 Dec 01; 36(6):903-11. PubMed ID: 2557537
    [Abstract] [Full Text] [Related]

  • 8. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
    Przegaliński E, Filip M, Bijak M, Wedzony K, Budziszewska B, Tokarski K, Maćkowiak M, Fijał K.
    Pol J Pharmacol; 1996 Dec 01; 48(1):13-22. PubMed ID: 9112623
    [Abstract] [Full Text] [Related]

  • 9. Increased serotonergic functions following adminstration of 1-(1-naphthyl) piperazine in propranolol injected rats.
    Perveen T, Rafiq R, Haider S, Haleem DJ.
    Pak J Pharm Sci; 2006 Jul 01; 19(3):194. PubMed ID: 16935825
    [Abstract] [Full Text] [Related]

  • 10. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML, Fuller RW, Kurz KD, Parli CJ, Mason NR, Meyers DB, Smallwood JK, Toomey RE.
    J Pharmacol Exp Ther; 1988 Jan 01; 244(1):106-12. PubMed ID: 3335993
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist.
    Rënyi L, Evenden JL, Fowler CJ, Jerning E, Kelder D, Lake-Bakaar D, Larsson LG, Mohell N, Sällemark M, Ross SB.
    J Pharmacol Exp Ther; 2001 Dec 01; 299(3):883-93. PubMed ID: 11714872
    [Abstract] [Full Text] [Related]

  • 13. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH, Günzler WA, Flohé L.
    Arzneimittelforschung; 1984 Dec 01; 34(11):1471-80. PubMed ID: 6084511
    [Abstract] [Full Text] [Related]

  • 14. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW, Snoddy HD.
    Endocrinology; 1979 Oct 01; 105(4):923-8. PubMed ID: 477605
    [Abstract] [Full Text] [Related]

  • 15. Flumezapine, an antagonist of central dopamine and serotonin receptors.
    Fuller RW, Mason NR.
    Res Commun Chem Pathol Pharmacol; 1986 Oct 01; 54(1):23-34. PubMed ID: 2879325
    [Abstract] [Full Text] [Related]

  • 16. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW, Hemrick-Luecke SK, Snoddy HD.
    J Pharmacol Exp Ther; 1994 Apr 01; 269(1):132-6. PubMed ID: 7513356
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptors.
    Fuller RW, Mason NR.
    Adv Exp Med Biol; 1981 Apr 01; 133():359-68. PubMed ID: 6172017
    [No Abstract] [Full Text] [Related]

  • 18. p,p'-DDT-induced alterations in brain serotonin metabolism.
    Chung Hwang E, Van Woert MH.
    Neurotoxicology; 1981 Dec 01; 2(4):649-57. PubMed ID: 6176920
    [Abstract] [Full Text] [Related]

  • 19. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM.
    Mol Pharmacol; 1985 Jun 01; 27(6):600-11. PubMed ID: 2860558
    [Abstract] [Full Text] [Related]

  • 20. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE.
    J Physiol (Paris); 1981 Jun 01; 77(2-3):351-62. PubMed ID: 7288650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.